Preval HealthAbout Preval Health
We help you reach your LDL goal and stay there.
Preval Health is an online clinic for prescription cholesterol treatment, available across the US. A board-certified preventive cardiologist founded it to make advanced lipid testing and the right medicine easier to get, and to keep following you before and after your numbers reach goal.
Most people call it cholesterol treatment. Clinicians call it lipid-lowering therapy, because ApoB counts the particles that carry cholesterol. Both names describe the same care.
Our Mission
Most people on treatment still sit above goal.
We help people with high cholesterol reach their LDL cholesterol (LDL-C) and ApoB goals, safely and for the long run. Proven medicines (high-intensity statins, ezetimibe, bempedoic acid and PCSK9 inhibitors) can get them there, but many people stay above goal. In a US registry of 5,006 people with heart or blood vessel disease, about two in three still had an LDL-C above 70 mg/dL after two years.
Many patients still need a service that orders ApoB and Lp(a) testing, prescribes to a goal, adjusts the plan and keeps checking in until they reach it.
We built Preval Health to be that service. It includes PCSK9 inhibitor prescriptions, a careful plan for people with statin intolerance, all paid in cash so treatment starts without an insurance wait.
The Problem
Primary care covers a lot in a short visit.
Primary care clinicians look after everything from blood pressure to cancer screening, often in a short visit. Adding ApoB and Lp(a) testing, combination therapy and the prior authorization paperwork for a PCSK9 inhibitor takes time that a busy visit doesn’t always have. We focus on that piece and work alongside your own clinician.
Many people look for answers on social media and wellness sites, where the advice often conflicts. Our free cholesterol guides give clear answers with sources, and our protocols follow the major cholesterol trials.
Our clinicians review your numbers, prescribe what the evidence supports and keep rechecking to reach goal and stay there.
22%
fewer major heart and stroke events for each 39 mg/dL lower LDL-C (CTT, 26 trials)
~1 in 2
people hospitalized for heart disease had LDL-C under 100 (Am Heart J 2009)
4
classes of LDL-lowering medicines our clinicians can prescribe: statins, ezetimibe, bempedoic acid, PCSK9 inhibitors
1 in 5
people have high Lp(a), an inherited risk factor (EAS 2022)
Sources: Cholesterol Treatment Trialists’ Collaboration, Lancet, 2010; Sachdeva et al., American Heart Journal, 2009; Kronenberg et al., European Heart Journal, 2022; GOULD registry, Cannon et al., JAMA Cardiology, 2021 (mission section).
Founder
Who writes our protocols.
Kaustubh Dabhadkar, MD, MPH, FACC
Founder
Dr. Dabhadkar is a board-certified preventive cardiologist practicing in Charlotte, North Carolina. He completed his internal medicine residency and Master of Public Health in Epidemiology at Emory University, followed by a fellowship in cardiovascular disease at Brown University.
He is an adjunct assistant professor at the University of North Carolina and a member of the American College of Cardiology’s Leadership Council on Preventive Cardiology. His research in cardiovascular epidemiology and prevention has been cited over 77,000 times.
He turns trial evidence into individual treatment plans, with a focus on people whose cholesterol stays above goal.
Treat your LDL to a goal.
Licensed clinicians prescribe FDA-approved medicines under protocols built on the major cholesterol trials.
Join the Waitlist